Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

NCT00371423 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: TAXUS Liberté™-SR
DEVICE: TAXUS Liberté™-SR

Sponsor

Boston Scientific Corporation